[menaerus]

> Who cares if pharmaceutical companies or any other business is slow to adopt the AI, the AI will capture that market entirely making those companies obsolete

It wouldn't because of things which are not of a technical nature. Trials for instance might take much longer than developing the drug. Or complying with whatever regulations of given industry which normally requires some heavy-lifting process which is normally run by humans.

[sudohalt]

In those cases the AI can spin up a shell corp and run the clinical trials, humans would administer the trials (maybe robots can do it). There is already hundreds of pharmaceutical companies so it isn’t difficult for an AI to spin up another and bring in humans when needed